Department of Radiotherapy & Oncology
Clinical Departments
- Anesthesia Department
- ICU & Pain Management
- COVID-19 /Isolation Ward
- Cardiology Department
- Dermatology Department
- E.N.T Department
- Gastroenterology
- Medical Unit I
- Medical Unit II
- Medical Unit III
- Medical Unit IV
- Modern Burn Unit
- Nephrology Department
- Neurosurgery Department
- Neurology Department
- Department of Radiotherapy & Oncology
Department of Radiotherapy & Oncology
Dr. Rana Atique Anwar Khan
Associate Professor & Head of Department atiqanwer9@gmail.com
INTRODUCTION OF DEPARTMENT
The Department of Radiotherapy & Oncology at Nishtar Medical University Hospital, Multan, provides cancer care through radiotherapy and chemotherapy services for patients from Multan and surrounding areas. We aim to deliver treatment in a safe and organized manner, with careful planning and respectful communication. Our team supports patients through assessment, treatment planning, therapy delivery and follow‑up, while coordinating with other departments whenever needed.
GOALS AND OBJECTIVES
- To provide safe, accurate, and timely radiotherapy for cancer patients, with patient comfort and safety as priorities.
- To maintain a clear radiotherapy workflow: assessment → immobilization → CT simulation → contouring → treatment planning (TPS) → plan verification/QA → treatment delivery → follow‑up.
- To deliver radiotherapy using available technology, including LINAC-based external beam radiotherapy, Cobalt-60 radiotherapy, 2D planning (Acuity) and 3D-CRT according to standard protocols.
- To ensure routine safety checks and quality assurance to support correct dose delivery and minimize treatment errors.
- To provide chemotherapy services with standard regimens, monitoring and supportive care.
- To improve coordination between OPD, ward, chemotherapy, simulation, planning and treatment areas to reduce delays and improve patient flow.
- To counsel patients and families regarding treatment steps and side effects and to manage toxicity early.
- To improve quality through clinical audit, research and regular academic activities (including Journal Club).
FACULTY
Faculty & Team
Our department team includes faculty members, doctors, medical physicists, technologists, nurses and support staff who work together to provide complete oncology care.
LIST OF FACULTY MEMBERS
Name | Designation | Qualification | Phone | |
Dr. Rana Atique Anwar Khan | Associate Professor & Head of Department | FCPS |
|
EDUCATIONAL ACTIVITIES
Undergraduate (MBBS):
The department contributes to MBBS teaching by delivering scheduled lectures and academic sessions for 4th Year and Final Year MBBS students. Teaching includes topic-based lectures, case-based discussions and orientation to radiotherapy workflow and basic oncology principles.
Postgraduate (FCPS Radiation Oncology):
The Department of Radiotherapy & Oncology is a CPSP-recognized training center for FCPS (Radiation Oncology). The department provides structured postgraduate training through supervised clinical practice, radiotherapy planning exposure (2D/3D planning), treatment delivery, ward/OPD activities and regular academic sessions including case discussions and Journal Club.
Monthly Journal Club
A departmental Journal Club is held on the first Saturday of every month to promote evidence‑based practice and improve clinical decision‑making.
RESEARCH
The department supports clinical research and audit work aimed at improving patient care. Our focus includes treatment outcomes, toxicity monitoring, and service improvement.
Publications
- Khan RAA et al. Comparison of different radiation doses for pain control in bone metastasis. Pakistan Journal of Intensive Care Medicine. December 2025.
- Anwar RA et al. Retrospective analysis of breast cancer subtypes, risk factors and lump features. International Journal of Research in Medical Sciences. 2025;13(4).
- Prevalence of Erectile Dysfunction after Pelvic Radiotherapy. Biological and Clinical Sciences Research Journal. 2024.
- Efficacy of Low-Dose Metronomic Chemotherapy in Metastatic Breast Cancer. Professional Medical Journal. 2024;31(12).
- Docetaxel vs Docetaxel plus Capecitabine in Triple Negative Breast Cancer. Biological and Clinical Sciences Research Journal. 2024.
- Safety and Efficacy of Rivaroxaban vs Enoxaparin in Cancer-Associated VTE. Biological and Clinical Sciences Research Journal. 2023.
- Neoadjuvant Docetaxel plus Carboplatin versus Epirubicin plus Cyclophosphamide followed by Docetaxel in Triple negative early staged Breast cancer. PJMHS. August 2022.
- Regional Lymph Node Radiotherapy Techniques in Breast Cancer. Life and Science. 2022.
- Concurrent Chemoradiation Regimens in Esophageal Cancer. Medical Forum. 2022.
- A Bioelectromagnetic Method to Prevent Pulmonary Fibrosis in COVID-19. Frontiers in Immunology. 2020.
- Concomitant Chemoradiation using Vinorelbine in Advanced Non-Small Cell Lung Carcinoma in Tertiary Care Hospital of Pakistan. Indian Journal of Natural Science. 2019.
- Vinorelbine as radiosensitizer in Pakistani patients with locally advanced unresectable head & neck cancer. IJEHSR. 2019.
Others Publications:
- Practical Experience of Oncothermia in Palliative and Radical Cancer Treatment – 26th Annual PSCO Conference, Multan (February 2025)
- Efficacy of Trastuzumab Biosimilar (Trizemra) in Triple Positive Breast Cancer – Onco Summit, Karachi (September 2024)
- Fulvestrant in Hormone-Resistant Breast Cancer – Thailand (May 2024)
- Role of Palbociclib and Letrozole in Metastatic Breast Cancer – Onco Summit, Karachi (July 2023)
- Effect of Sofosbuvir and Ribavirin on Therapeutic Efficacy of Sorafenib in Advanced Hepatocellular Carcinoma – ESMO Asia, Singapore (2017)
- Vinorelbine as a Radiosensitizer in Locally Advanced Head & Neck Cancer – PSCO Conference, Lahore (2009)
PUBLISHED BOOK
Currently, no departmental book publication is registered.
HEALTH SERVICES / STATE OF ART FACILITIES
The Department of Radiotherapy & Oncology provides radiotherapy and chemotherapy services supported by essential planning and diagnostic facilities. We focus on safe treatment delivery, proper documentation and patient support at every step.
Clinical Services
- Oncology outpatient assessment, follow‑up and treatment counseling
- Radiotherapy planning and delivery
- Chemotherapy services with monitoring and supportive care
- Inpatient care for patients requiring admission and close observation
Radiotherapy Facilities
- LINAC (Linear Accelerator): Used for modern external beam radiotherapy with precise dose delivery.
- Acuity System: Used for 2D treatment planning (where required), alongside CT‑based planning for 3D‑CRT.
- Cobalt-60 Unit: Available for radiotherapy treatment as per clinical indication and departmental protocols.
- 3D Conformal Radiotherapy (3D‑CRT): CT‑based simulation and TPS‑supported planning to improve treatment accuracy.
Planning & Imaging Support
- Acuity system for 2D planning
- CT Simulator (CT‑Sim)
- Treatment Planning System (TPS)
- Ultrasound
- Mammography
Systemic Therapy
- Chemotherapy facility for delivery of standard regimens and supportive care
Inpatient Facility
- Ward 25‑B with 24 beds for admitted patients needing oncology care and monitoring
Facility Images (Radiotherapy & Planning)
PROJECTS / DEPARTMENTAL EXTENSION / SPECIAL FEATURES
Oncology Block (Under Construction)
A new oncology facility is currently under construction and is planned as a five‑storey building with 100 beds. The aim is to provide chemotherapy, radiotherapy, and diagnostic services under a single roof, improving patient convenience and coordination of care.
Expected completion: June 2026.
PET Cyclotron Facility (In Progress)
A dedicated PET cyclotron facility is also being developed to strengthen advanced diagnostic and staging services.
Expected completion: April 2026.